Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-06-03

Clinical Trial Update: The Targeted Neurocognitive Training (TNT) Study [NA]

View source ↗

Summary

A clinical trial evaluating targeted neurocognitive training for HIV-positive individuals and older adults has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HIV, Aging | NA | Status: SUSPENDED